August 31, 2026

West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a formidable player in the healthcare sector, is capturing the attention of investors with its robust market presence and promising growth metrics. As a..

Doximity, Inc. (DOCS): Investor Outlook Reveals 11.40% Potential Upside Amidst Strong Market Dynamics

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, is capturing investor attention with its promising growth metrics and significant market presence. With a market capitalization..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking a 6.41% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with a robust market capitalization of $35.16 billion. As a major player in the healthcare industry, Royalty Pharma offers..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring a 29% Upside Potential

For investors eyeing the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents a compelling opportunity, with a notable potential upside of 29.22% based on the current average target price..

Universal Health Services, Inc. (UHS) Stock Analysis: Strong Revenue Growth and a 12.98% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of $10.12 billion, this Pennsylvania-based company operates a..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 13.36% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, is capturing investor attention with a market cap of $43.38 billion...

Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently capturing investor attention with its diverse product portfolio and a notable potential upside of 9.94%. Headquartered..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.68% Upside Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the medical distribution sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Market Challenges with Robust Revenue Growth

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to demonstrate resilience in the ever-evolving pharmaceutical landscape. With a market capitalization of $136 billion, the company maintains..

Penumbra, Inc. (PEN) Stock Analysis: Unraveling the 12.48% Potential Upside

Penumbra, Inc. (NYSE: PEN) stands as a formidable player in the healthcare sector, specializing in the design, development, and marketing of innovative medical devices. With a market capitalization of $12.67..

Guardant Health, Inc. (GH) Investor Outlook: A 20% Upside Potential Amidst Rapid Revenue Growth

Guardant Health, Inc. (GH) stands at the forefront of the precision oncology sector, offering innovative solutions in diagnostics and research. With a significant market capitalization of $21.67 billion, this Palo..

Elanco Animal Health (ELAN) Stock Analysis: Unveiling a 29% Upside Potential Amidst Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector’s drug manufacturing niche, has caught the attention of investors with its compelling growth prospects. The company, headquartered..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with a -15.14% Potential Downside

For investors keeping a keen eye on the medical devices industry, Bio-Rad Laboratories, Inc. (NYSE: BIO) presents a fascinating case study. With a market capitalization of $10.37 billion, Bio-Rad stands..

Bruker Corporation (BRKR) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Bruker Corporation (BRKR), a prominent player in the medical devices industry, has been making waves in the healthcare sector with its scientific instruments and analytical solutions. Headquartered in Billerica, Massachusetts,..

Ascendis Pharma A/S (ASND): Investor Outlook Reveals a Promising 27% Upside Potential in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical company, has been making significant waves in the healthcare sector, particularly within the biotechnology industry. With a robust market capitalization of $16.26..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Waters of TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a pioneering company in the healthcare sector, is capturing attention with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Headquartered..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 41.55% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its notable market presence and promising growth trajectory. With a market..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Biotech Giant with 18.87% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a formidable entity in the biotechnology sector, commanding a significant market capitalization of $44.56 billion. Headquartered in Redwood City, California, the company is..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a Potential 18% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. With a robust market capitalization of $5.74 billion,..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 23% Upside Opportunity

HealthEquity, Inc. (NASDAQ: HQY) stands at the nexus of healthcare and technology, delivering innovative solutions through its comprehensive services platform. With a market capitalization of $7.97 billion, HealthEquity is a..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds